Results 41 to 50 of about 2,109,479 (260)

Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia [PDF]

open access: yes, 2017
The most worrying complication of replacement therapy for severe hemophilia A and B is currently the occurrence of inhibitory alloantibodies against infused factor VIII and factor IX, respectively.
Franchini, Massimo   +6 more
core   +1 more source

Protease: Serpin complexes to assess contact system and intrinsic pathway activation

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2020
Mounting evidence suggests that a variety of disease states are pathophysiologically related to activation of the contact system in vivo. The plasma contact system is composed of a cascade of serine proteases initiated by surface activation of factor XII,
Michael W. Henderson   +6 more
doaj   +1 more source

$\pi\Xi$ phase shifts and CP Violation in ${\Omega\to\pi\Xi}$ Decay

open access: yes, 2003
In the study of CP violation signals in ${\O}\to\pi\Xi$ nonleptonic decays, the strong $J$=3/2 $P$ and $D$ phase shifts for the $\pi\Xi$ final-state interactions are needed. These phases are calculated using an effective Lagrangian model, including $\Xi$,
A. Pais   +32 more
core   +1 more source

Coronary artery stenting in a patient with factor XI deficiency

open access: yesCardiology Plus, 2019
Factor XI deficiency is a rare coagulopathy which has a higher risk of bleeding following trauma or an operation. Stable coronary artery disease patients complicated by factor XI deficiency draw extraordinary caution when coronary artery stents are ...
Mingqiang Fu   +4 more
doaj   +1 more source

Factor XI as a Therapeutic Target [PDF]

open access: yesArteriosclerosis, Thrombosis, and Vascular Biology, 2016
Factor XIa is a plasma serine protease that contributes to thrombin generation primarily through proteolytic activation of factor IX. Traditionally considered part of the intrinsic pathway of coagulation, several lines of evidence now suggest that factor XIa serves as an interface between the vitamin-K–dependent thrombin generation mechanism and the ...
David, Gailani, Andras, Gruber
openaire   +2 more sources

Correção endovascular de aneurisma de aorta abdominal e artéria ilíaca comum esquerda em paciente com hemofilia C grave Endovascular repair of abdominal aortic aneurysm and left common iliac artery in a patient with severe hemophilia C

open access: yesJornal Vascular Brasileiro, 2012
A deficiência do fator XI, também conhecida como hemofilia C, é uma doença hematológica hereditária rara, que se manifesta clinicamente com hemorragia persistente após cirurgias, traumas, menorragias e extrações dentárias.
Sergio Quilici Belczak   +6 more
doaj   +1 more source

Scalar perturbations of Eddington-inspired Born-Infeld braneworld

open access: yes, 2017
We consider the scalar perturbations of Eddington-inspired Born-Infeld braneworld models in this paper. The dynamical equation for the physical propagating degree of freedom $\xi(x^\mu,y)$ is achieved by using the Arnowitt-Deser-Misner decomposition ...
Du, Xiao-Long   +3 more
core   +1 more source

Ground state energy of unitary fermion gas with the Thomson Problem approach [PDF]

open access: yes, 2006
The dimensionless universal coefficient $\xi$ defines the ratio of the unitary fermions energy density to that for the ideal non-interacting ones in the non-relativistic limit with T=0.
Bishop R A   +16 more
core   +1 more source

The hemostatic role of factor XI [PDF]

open access: yesThrombosis Research, 2016
Coagulation factor (F)XI has been described as a component of the early phase of the contact pathway of blood coagulation, acting downstream of factor XII. However, patients deficient in upstream members of the contact pathway, including FXII and prekallikrein, do not exhibit bleeding complications, while FXI-deficient patients sometimes experience ...
Cristina, Puy   +2 more
openaire   +2 more sources

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy